文献速递脑血管病神经重症与神经感染神经肌肉病

神经科试验中序贯结局的统计学实践:文献综述

Statistical Practice of Ordinal Outcome Analysis in Neurologic Trials: A Literature Review.
PubMed 文献 · Neurology · 2025-02-03

该文献综述检索了2015年1月1日至2023年11月1日发表在高影响期刊上的70项急性神经疾病随机对照试验,评估序贯结局的统计分析方法。结果显示,66%的试验保留了完整排序信息,但62%未检验比例优势假设;31%将序贯结局二分化;59%在多个时间点评估结局,但仅7%进行了纵向数据分析。作者结论认为序贯结局分析方法差异大,排序信息和重复测量信息未被充分利用。

要点

  • 70项急性神经疾病随机对照试验中,66%保留序贯结局完整排序信息,常用比例优势模型。
  • 使用比例优势模型的33项试验中,62%未评估比例优势假设。
  • 31%的试验将序贯结局二分化,各量表切点差异明显。

核心结论

  • 当前神经科试验中序贯结局的统计分析方法差异很大,二分化处理和关注单一时间点较常见,导致结局排序信息和重复测量信息未被充分利用。
  • 需要进一步研究以明确在更有效利用结局数据的方法中,最大化统计功效、做出假设和允许直观解释之间的平衡。

研究设计与样本

  • 文献综述:检索PubMed中2015年1月1日至2023年11月1日发表在高影响期刊上的随机对照试验,涵盖5种急性单相神经疾病(卒中、创伤性脑损伤、蛛网膜下腔出血、脑膜炎和吉兰-巴雷综合征)。
  • 纳入标准为以序贯量表作为主要或次要疗效结局的随机对照试验;由两名独立评价者进行筛选和数据提取。
  • 共纳入70项随机对照试验:卒中36项、创伤性脑损伤13项、蛛网膜下腔出血10项、脑膜炎7项、吉兰-巴雷综合征4项。

主要发现

  • 70项试验中,46项(66%)保留了完整排序信息,其中33项(72%)常用比例优势模型。
  • 使用比例优势模型的33项试验中,23项(62%)未处理比例优势假设。
  • 70项试验中,22项(31%)将序贯结局二分化,各序贯量表的切点差异明显。
  • 70项试验中,41项(59%)在多个时间点评估序贯结局,但其中仅3项(7%)进行了某种形式的纵向数据分析。
  • 70项研究中,48项(69%)报告了协变量调整;分析所选时间点在各神经疾病内存在差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Ordinal scales are widely adopted as outcome measures in neurologic randomized controlled trials (RCTs). We aimed to evaluate which statistical methods have been used to test and estimate treatment effects from ordinal outcomes in recent RCTs across a range of acute neurologic diseases. METHODS: We searched PubMed for RCTs in 5 acute monophasic neurologic diseases (stroke, traumatic brain injury [TBI], subarachnoid hemorrhage [SAH], meningitis, and Guillain-Barré syndrome [GBS]) published in high-impact journals between January 1, 2015, and November 1, 2023. Trials had to report on an ordinal scale as the primary or secondary efficacy outcome. Two independent reviewers performed study screening and data extraction. We evaluated the results to determine how investigators (1) addressed the ordinal nature of outcomes, (2) assessed and reported key assumptions, (3) used longitudinal measurements, and (4) adjusted for prognostic covariates. RESULTS: We reviewed 70 RCTs for treatment evaluations in stroke (n = 36), TBI (n = 13), SAH (n = 10), meningitis (n = 7), and GBS (n = 4). In 46 of 70 trials (66%), investigators retained the full ordering information, commonly analyzed using a proportional odds model (33/46 trials, 72%). The proportional odds assumption was not addressed in 23 of 33 trials (62%). In 22 of 70 trials (31%), the ordinal outcome was dichotomized, with notable variation in the cut-point for each ordinal scale. In 41 of 70 trials (59%), the ordinal outcome was assessed at multiple time points while some form of longitudinal data analysis was performed in only 3 of these 41 studies (7%). The time point chosen for analysis varied within neurologic conditions. Covariate adjustment was reported in 48 of 70 studies (69%). DISCUSSION: There is a large variation in the current practice of analyzing ordinal outcomes in neurologic trials. Dichotomization and focus on a single time point are common; therefore, information contained in the rank ordering of the outcome and repeated measurements is not fully used. Further research needs to clarify the balance between maximizing the statistical power, making assumptions, and allowing for straightforward interpretations in approaches that make more effective use of the outcome data.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Long Y, de Ruiter SC, Luijten LWG, et al. Statistical Practice of Ordinal Outcome Analysis in Neurologic Trials: A Literature Review. Neurology. 2025. PMID: 39899785. doi:10.1212/WNL.0000000000210229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。